Participated · Series A · Jun 2026

Orbio builds AI agents that interview candidates, assess fit, monitor employee output and conduct daily check-ins across an employee’s lifecycle. The company was founded in 2025 by Sergi Bastardas, Nacho Travesí and Antonio Melé and counts customers such as Poke, YUM! Brands and The Stepping Stones Group. Orbio says customers are transitioning from pilots to full deployments and reports that at The Stepping Stones Group it now runs the company’s full US operation, with 20% more candidates progressing to hire. Financially, Orbio has raised $26 million to date, including the newly announced $21 million Series A led by Dawn Capital and earlier backers Visionaries and 2100 Ventures. The startup plans to use the new capital to hire and develop additional AI agents and expand deployments.

Led · Seed · Apr 2026

TietAI develops Hydra, an artificial intelligence layer intended to unify and optimize hospital operations across data ingestion, orchestration of clinical flows, scheduling, billing and laboratory interpretation. The company says Hydra is meant to act as an invisible operational infrastructure to coordinate disparate hospital systems and reduce administrative burden for clinical teams. Following the €2.5 million seed round, TietAI plans to expand its engineering team, accelerate certified deployments in hospitals across Spain and Europe, and build additional operational agents for scheduling, diagnosis, care transitions, billing and lab interpretation. Leadership cited preparation for regulatory milestones—specifically the EU AI Regulation and the European Health Data Space (EHDS)—as a use-case driver for commercialization and product maturity. The articles identify Roberto Cruz as CEO and cofounder and David Rey Blanco as COO and cofounder. No revenue, user or other operating metrics were disclosed in the coverage.

Participated · Seed · Dec 2025

Punto Health is developing a dementia care platform that combines speech-based digital biomarkers with personalized daily care plans and clinician dashboards to shift cognitive care toward earlier identification and proactive, day-to-day support. The system forms a connected ecosystem that guides patients and carers while streamlining monitoring and care coordination for clinicians. Over the past year, the team co-designed and clinically validated the product with partners such as Ace Alzheimer Center Barcelona, several NHS Foundation Trusts, and multiple Spanish hospitals, reaching more than 2,000 individuals in the process. Feedback from these patients, carers, and clinicians has shaped product features aimed at usability and continuous engagement. With fresh seed capital, the company plans to scale its technology, expand hiring in London and Barcelona, and widen access to proactive dementia care for additional families. Financially, Punto Health has secured $2.7 million to fund these growth initiatives. The company is led by co-founder and CEO Anna Muñoz Farré.

Participated · Seed · Dec 2025

Adcities operates an out-of-home (OOH) advertising network that layers geocontextual data onto digital billboards and other outdoor inventory to enable highly targeted, measurable, and actionable campaigns. The platform is already used by more than 25 brands, including Telefónica, Decathlon, and Mapfre, demonstrating early commercial traction. Co-founded by CEO Manuel Ferreira Lorenzo and CPO/CTO Jacobo Peleteiro Lumbreras, the company positions itself at the intersection of adtech and data analytics, aiming to bring the precision of digital advertising to physical spaces. With fresh capital in hand, Adcities plans to expand its operations, accelerate product development, and broaden its market reach across additional geographies and advertiser segments. The startup’s differentiation lies in its ability to fuse location intelligence with outdoor media, offering advertisers real-time campaign activation and performance insights. Financially, the company has secured over €3 million in seed funding, giving it resources to scale its network and technology stack. While revenue figures are not disclosed, the existing customer roster and institutional backing suggest early product-market fit.